Primary dermal melanoma: A case report and molecular characterization

Journal of Dermatology

Volumn 36, Issue 6, 2009, Pages 346-352

  Hida, Yasutoshi ^a   Kubo, Yoshiaki ^a   Miyajima, Osamu ^a   Arase, Seiji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Clear cell sarcoma; EWS ATF1 fusion transcript; KIT; Metastatic melanoma; Primary dermal melanoma

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; BETA INTERFERON; CISPLATIN; DACARBAZINE; IMATINIB; NIMUSTINE; RNA BINDING PROTEIN EWS; STEM CELL FACTOR; TAMOXIFEN; VINCRISTINE SULFATE;

ADULT; ARTICLE; ASCITES TUMOR; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DETERIORATION; DRUG DOSE REDUCTION; FEMALE; FUSION GENE; HISTOPATHOLOGY; HUMAN; LUNG METASTASIS; MELANOMA; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; OVARY METASTASIS; PHYSICAL EXAMINATION; PRIMARY DERMAL MELANOMA; PRIMARY TUMOR; SKIN SURGERY; THROMBOCYTOPENIA;

ADULT; DNA MUTATIONAL ANALYSIS; FATAL OUTCOME; FEMALE; GENES, RAS; HUMANS; MELANOMA; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-KIT; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 66949127217     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2009.00650.x     Document Type: Article

References (30)

1. Anbari KK, Schuchter LM, Bucky LP et al. Melanoma of unknown primary site. Cancer 1997 79 : 1816 1821.
2. Schlagenhauff B, Stroebel W, Ellwanger U et al. Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma. Cancer 1997 80 : 60 65.
3. Giuliano AE, Moseley HS, Morton DL. Clinical aspects of unknown primary melanoma. Ann Surg 1980 191 : 98 104. (Pubitemid 10140808)
4. Bowen GM, Chang AE, Lowe L, Hamilton T, Patel R, Johonson TM. Solitary melanoma confined to the dermal and/or subcutaneous tissue. Arch Dermatol 2000 136 : 1397 1399.
5. Swetter SM, Ecker PM, Johonson DL, Harvell JD. Primary dermal melanoma: a distinct subtype of melanoma. Arch Dermatol 2004 140 : 99 103. (Pubitemid 38090276)
6. Lucas DR, Nascimento AG, Sim FH. Clear cell sarcoma of soft tissues: Mayo Clinic experience with 35 cases. Am J Surg Pathol 1992 16 : 1197 1204. (Pubitemid 23004425)
7. Montgomery EA, Meis JM, Ramos AG, Frisman DM, Martz KL. Clear cell sarcoma of tendons and aponeuroses. Int J Surg Pathol 1993 1 : 89 100.
8. Curtin JA, Fridlyand J, Kageshita T et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005 353 : 2135 2147. (Pubitemid 41653105)
9. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006 24 : 4340 4346. (Pubitemid 46630793)
10. Funasaka Y, Boulton T, Cobb M et al. c-Kit kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulated mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 1992 3 : 197 209. (Pubitemid 23084551)
11. Dim DC, Cooley LD, Miranda RN. Clear cell sarcoma of tendons and aponeuroses: a review. Arch Pathol Lab Med 2007 131 : 152 156. (Pubitemid 46174153)
12. Davis IJ, Kim JJ, Ozsolak F et al. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell 2006 9 : 473 484. (Pubitemid 43832189)
13. Davies H, Bignell GR, Cox C et al. Mutations of the BRAF gene in human cancer. Nature 2002 417 : 949 954. (Pubitemid 34716871)
14. Houben R, Becker JC, Kappel A et al. Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis. J Carcinog 2004 3 : 6 18.
15. Coindre J-M, Hostein I, Terrier P et al. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues. Cancer 2006 107 : 1055 1064.
16. Seike T, Matsumoto K, Nakanishi H, Hashimoto I, Kubo Y, Arase S. Malignant melanoma of soft parts (clear cell sarcoma): a case report. J Dermatol 2003 30 : 550 555. (Pubitemid 36950769)
17. Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001 19 : 3635 3648. (Pubitemid 32786276)
18. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 2004 28 : 31 40. (Pubitemid 38031618)
19. Deyrup AT, Althof P, Zhou M et al. Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. Am J Surg Pathol 2004 28 : 1579 1586. (Pubitemid 39564962)
20. Wong CW, Fan YS, Chan TL et al. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J Clin Pathol 2005 58 : 640 644. (Pubitemid 40814027)
21. Panagopoulos I, Mertens F, Isaksson M, Mandahl N. Absence of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses). Cancer Genet Cytogenet 2005 156 : 74 76.
22. Hornick JL, Fletcher CDM. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002 117 : 188 193. (Pubitemid 34823657)
23. Garcia JJ, Kramer MJ, Mackey ZB, O'Donnell RJ, Horvai AE. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma. Arch Pathol Lab Med 2006 130 : 343 348.
24. Shen SS, Zhang PS, Eton O, Prieto VG. Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array. J Cutan pathol 2003 30 : 539 547. (Pubitemid 37255550)
25. Guerriere-Kovach PM, Hunt EL, Patterson JW, Glembocki DJ, English III JC, Wick MR. Primary melanoma of the skin and cutaneous melanomatous metastases. Am J Clin pathol 2004 122 : 70 77.
26. Janku F, Novotny J, Julis I et al. KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients. Melanoma Res 2005 15 : 251 256. (Pubitemid 41127460)
27. Zhu YI, Fitzpatrick JE. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma. J Cutan Pathol 2006 33 : 33 37.
28. Cassarino DS, Cabral ES, Kartha RV, Swetter SM. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma. Arch Dermatol 2008 144 : 49 56. (Pubitemid 351159389)
29. Hisaoka M, Ishida T, Kuo T-T et al. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis 33 cases. Am J Surg Pathol 2008 32 : 452 460.
30. Ivan D, Niveiro M, Diwan AH et al. Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec™). J Cutan Pathol 2006 33 : 280 285.